SpringerLink
Log in

Radiotherapy alone versus chemoradiotherapy for stage I anal squamous cell carcinoma: a systematic review and meta-analysis

  • Review
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Patients with stage I anal squamous cell carcinoma (SCC) have been underrepresented in landmark trials showing superiority of chemoradiotherapy over radiotherapy for definitive treatment. This review aims to elucidate whether definitive treatment with radiotherapy versus chemoradiotherapy is associated with differences in survival and treatment-related toxicity outcomes in patients with stage I anal SCC.

Methods

Medline, EMBASE, and CENTRAL were searched as of November 2020 to identify studies comparing outcomes of radiotherapy versus chemoradiotherapy for non-operative treatment of patients with stage I anal SCC. The primary outcomes were 5-year overall survival and 5-year disease-free survival. The secondary outcome was treatment-related toxicities. A pairwise meta-analysis was performed using an inverse-variance random-effects model.

Results

From 2174 citations, 5 retrospective studies with 415 patients treated with radiotherapy and 3784 patients treated with chemoradiotherapy were included. Patients treated with chemoradiotherapy had an increased 5-year overall survival (RR 1.18, 95% CI 1.10–1.26, p < 0.00001, I2 = 0%) but no significant difference in 5-year disease-free survival (RR 1.01, 95% CI 0.92–1.11, p = 0.87, I2 = 0%). Treatment-related toxicities could not be meta-analyzed due to heterogeneity. Limited data from individual studies suggested an increased frequency of select toxicities with chemoradiotherapy.

Conclusion

Radiotherapy may be an appropriate alternative to chemoradiotherapy for patients with stage I anal SCC who may be unable to tolerate chemotherapy-related toxicity; however, chemoradiotherapy remains the gold standard. Larger prospective studies comparing strategies for this select patient population are needed to clarify whether treatment can be de-escalated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Uronis HE, Bendell JC (2007) Anal cancer: an overview. Oncologist 12:524–534. https://doi.org/10.1634/theoncologist.12-5-524

    Article  PubMed  Google Scholar 

  2. Salati SA (2012) Anal cancer : a review. Int J Health Sci (Qassim) 6:206–230. https://doi.org/10.12816/0006000

  3. Eng C, Messick C, Glynne-Jones R (2019) The management and prevention of anal squamous cell carcinoma. Am Soc Clin Oncol Educ B 216–225. https://doi.org/10.1200/edbk_237433

  4. Symer MM, Yeo HL (2018) Recent advances in the management of anal cancer [version 1; peer review: 2 approved]. F1000Research 7:1–8. https://doi.org/10.12688/F1000RESEARCH.14518.1

  5. Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon rectum 17:354–356. https://doi.org/10.1007/BF02586980

    Article  CAS  PubMed  Google Scholar 

  6. Leichman L, Nigro N, Vaitkevicius VK, Considine B, Buroker T, Bradley G, Seydel HG, Olchowski S, Cummings G, Leichman C, Baker L (1985) Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med 78:211–215. https://doi.org/10.1016/0002-9343(85)90428-0

    Article  CAS  PubMed  Google Scholar 

  7. Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, Delaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39:651–657. https://doi.org/10.1016/S0360-3016(97)00329-5

    Article  CAS  PubMed  Google Scholar 

  8. John M, Pajak T, Flam M, et al (1996) Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am

  9. Goodman KA, Julie D, Cercek A, Cambridge L, Woo KM, Zhang Z, Wu AJ, Reidy DL, Segal NH, Stadler ZK, Saltz LB (2017) Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer. Int J Radiat Oncol Biol Phys 98:1087–1095. https://doi.org/10.1016/j.ijrobp.2017.03.022

    Article  CAS  PubMed  Google Scholar 

  10. Meulendijks D, Dewit L, Tomasoa NB, van Tinteren H, Beijnen JH, Schellens JHM, Cats A (2014) Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Br J Cancer 111:1726–1733. https://doi.org/10.1038/bjc.2014.467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB III, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA - J Am Med Assoc 299:1914–1921. https://doi.org/10.1001/jama.299.16.1914

    Article  CAS  Google Scholar 

  12. James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial. Lancet Oncol 14:516–524. https://doi.org/10.1016/S1470-2045(13)70086-X

    Article  CAS  PubMed  Google Scholar 

  13. NCCN (2020) NCCN clinical practice guidelines in oncology (NCCN guidelines®) anal carcinoma. Version 2:2020

    Google Scholar 

  14. Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25:10–20. https://doi.org/10.1093/annonc/mdu159

    Article  Google Scholar 

  15. Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ (1986) Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 4:1748–1757. https://doi.org/10.1200/JCO.1986.4.12.1748

    Article  CAS  PubMed  Google Scholar 

  16. Northover JMA, Arnott SJ, Cunningham D et al (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 348:1049–1054. https://doi.org/10.1016/S0140-6736(96)03409-5

    Article  Google Scholar 

  17. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049. https://doi.org/10.1200/JCO.1997.15.5.2040

    Article  CAS  PubMed  Google Scholar 

  18. Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jitlal M, Ledermann J (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR anal cancer trial (ACT I). Br J Cancer 102:1123–1128. https://doi.org/10.1038/sj.bjc.6605605

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Newman G, Calverley DC, Acker BD, Manji M, Haya J, Flores AD (1992) The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988. Radiother Oncol 25:196–202. https://doi.org/10.1016/0167-8140(92)90268-Y

    Article  CAS  PubMed  Google Scholar 

  20. Martenson JA, Gunderson LL (1993) External radiation therapy without chemotherapy in the management of anal cancer. Cancer 71:1736–1740. https://doi.org/10.1002/1097-0142(19930301)71:5<1736::AID-CNCR2820710506>3.0.CO;2-F

    Article  PubMed  Google Scholar 

  21. Touboul E, Schlienger M, Buffat L, et al (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer. https://doi.org/10.1002/1097-0142(19940315)73:6<1569::AID-CNCR2820730607>3.0.CO;2-F

  22. Buckstein M, Arens Y, Wisnivesky J, Gaisa M, Goldstone S, Sigel K (2018) A population-based cohort analysis of chemoradiation versus radiation alone for defnitive treatment of stage I anal cancer in older patients. Dis Colon rectum 61:787–794. https://doi.org/10.1097/DCR.0000000000001103

    Article  PubMed  PubMed Central  Google Scholar 

  23. Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG (2010) Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys 78:1413–1419. https://doi.org/10.1016/j.ijrobp.2009.09.046

    Article  PubMed  Google Scholar 

  24. Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, Welton ML, Shelton A, Kapp DS, Koong AC, Goodman KA, Chang DT (2011) Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 117:3342–3351. https://doi.org/10.1002/cncr.25901

    Article  PubMed  Google Scholar 

  25. Elson JK, Kharofa JR (2017) IMRT improves survival and reduces treatment time in squamous cell carcinoma of the anal canal: a National Cancer Database Study. Int J Radiat Oncol 99:E146. https://doi.org/10.1016/j.ijrobp.2017.06.950

    Article  Google Scholar 

  26. Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86:27–33. https://doi.org/10.1016/j.ijrobp.2012.09.023

    Article  CAS  PubMed  Google Scholar 

  27. Miller ED, Diaz Pardo DA, Arnett ALH, Abushahin L, Husain S, ** N, Williams TM, Bazan JG Jr (2020) Stage I squamous cell carcinoma of the anus: is radiation therapy alone sufficient treatment? Int J Radiat Oncol 108:e601–e602. https://doi.org/10.1016/j.ijrobp.2020.07.1833

    Article  Google Scholar 

  28. De Bari B, Lestrade L, Pommier P et al (2015) Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients. Cancer Investig 33:114–120. https://doi.org/10.3109/07357907.2014.1001898

    Article  CAS  Google Scholar 

  29. Zilli T, Schick U, Ozsahin M, Gervaz P, Roth AD, Allal AS (2012) Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy? Radiother Oncol 102:62–67. https://doi.org/10.1016/j.radonc.2011.09.015

    Article  PubMed  Google Scholar 

  30. Kole AJ, Stahl JM, Park HS, Khan SA, Johung KL (2017) Predictors of nonadherence to NCCN guideline recommendations for the management of stage I anal canal cancer. JNCCN J Natl Compr Cancer Netw 15:355–362. https://doi.org/10.6004/jnccn.2017.0035

    Article  Google Scholar 

  31. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097

    Article  Google Scholar 

  32. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD RD (2000) MOOSE guidelines for meta-analyses and systematic reviews of observational studies. Jama

  33. Cummings BJ, Keane TJ, O’Sullivan B et al (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115–1125. https://doi.org/10.1016/0360-3016(91)90265-6

    Article  CAS  PubMed  Google Scholar 

  34. Fallai C, Cerrotta A, Valvo F, Badii D, Olmi P (2007) Anal carcinoma of the elderly treated with radiotherapy alone or with concomitant radio-chemotherapy. Crit Rev Oncol Hematol 61:261–268. https://doi.org/10.1016/j.critrevonc.2006.09.003

    Article  PubMed  Google Scholar 

  35. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716. https://doi.org/10.1046/j.1445-2197.2003.02748.x

    Article  PubMed  Google Scholar 

  36. Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:1–13. https://doi.org/10.1186/1471-2288-14-135

    Article  Google Scholar 

  37. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. Br Med J 333:597–600

    Article  Google Scholar 

  38. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327:557–560

    Article  Google Scholar 

  39. McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Medica. https://doi.org/10.11613/bm.2012.031

  40. Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A (2009) Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the national cancer data base. Dis Colon rectum 52:624–631. https://doi.org/10.1007/DCR.0b013e31819eb7f0

    Article  PubMed  Google Scholar 

  41. Newcomb PA, Carbone PP (1993) Cancer treatment and age: patient perspectives. J Natl Cancer Inst 85:1580–1584. https://doi.org/10.1093/jnci/85.19.1580

    Article  CAS  PubMed  Google Scholar 

  42. Kutner JS, Vu KO, Prindiville SA, Byers TE (2000) Patient age and cancer treatment decisions: patient and physician views. Cancer Pract 8:114–119. https://doi.org/10.1046/j.1523-5394.2000.83004.x

    Article  CAS  PubMed  Google Scholar 

  43. Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66:337–350. https://doi.org/10.3322/caac.21342

    Article  PubMed  Google Scholar 

  44. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS (1989) Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 7:781–789

    Article  CAS  Google Scholar 

  45. Giroux L, Bettez P, Giroux L (1985) Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. Am J Kidney Dis 6:28–39. https://doi.org/10.1016/S0272-6386(85)80035-4

    Article  CAS  PubMed  Google Scholar 

  46. Cancer Care Ontario (2016) Drug formulary – mitomycin. CCO Formulary. https://www.cancercareontario.ca/en/drugformulary/drugs/mitomycin. Accessed 22 November 2020

  47. Yuan C, Parekh H, Allegra C, George TJ, Starr JS (2019) 5-FU induced cardiotoxicity: case series and review of the literature. Cardio-Oncology. 5:13. https://doi.org/10.1186/s40959-019-0048-3

    Article  PubMed  PubMed Central  Google Scholar 

  48. Moding EJ, Kastan MB, Kirsch DG (2013) Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 12:526–542

    Article  CAS  Google Scholar 

  49. Ramnath N, Dilling TJ, Harris LJ, Kim AW, Michaud GC, Balekian AA, Diekemper R, Detterbeck FC, Arenberg DA (2013) Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e314S–e340S. https://doi.org/10.1378/chest.12-2360

    Article  CAS  PubMed  Google Scholar 

  50. NCCN (2020) NCCN clinical practice guidelines in oncology (NCCN guidelines®) older adult oncology. Version 1:2020

    Google Scholar 

  51. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH (2010) Long-term quality of life after radiotherapy for the treatment of anal cancer. Cancer. 116:822–829. https://doi.org/10.1002/cncr.24906

    Article  PubMed  PubMed Central  Google Scholar 

  52. Fredman ET, Abdel-Wahab M, Kumar AMS (2017) Influence of radiation treatment technique on outcome and toxicity in anal cancer. J Radiat Oncol 6:413–421. https://doi.org/10.1007/s13566-017-0326-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. ECOG-ACRIN Cancer Research Group. Lower-dose chemoradiotherapy in treating patients with early-stage anal cancer, the DECREASE study. ClinicalTrials.gov. Identifier: NCT04166318

  54. Gao X, Goffredo P, Kahl AR, Charlton ME, Weigel RJ, Hassan I (2020) Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: a population-based analysis. Eur J Surg Oncol 46:1663–1667. https://doi.org/10.1016/j.ejso.2020.03.003

    Article  PubMed  Google Scholar 

  55. Pedersen TB, Kildsig J, Serup-Hansen E, Gocht-Jensen P, Klein MF (2020) Outcome following local excision of T1 anal cancers—a systematic review. Int J Color Dis 35:1663–1671

    Article  CAS  Google Scholar 

  56. Chai CY, Cao HT, Awad S, Massarweh NN (2018) Management of stage I squamous cell carcinoma of the anal canal. In: JAMA Surgery.

  57. Youssef I, Osborn V, Lee A, et al (2019) Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1–T2N0) anal squamous cell carcinoma. J Gastrointest Oncol 10:616–622. https://doi.org/10.21037/jgo.2019.02.06

  58. Goffredo P, Utria AF, Hrabe JE, Gribovskaja-Rupp I, Kapadia MR, Hassan I (2019) The role of multiagent chemoradiation in the management and prognosis of anal squamous cell carcinoma. J Gastrointest Surg 23:712–719. https://doi.org/10.1007/s11605-018-04068-x

    Article  PubMed  Google Scholar 

  59. Almaazmi H, Taylor JP, Stem M, et al (2020) Anal squamous cell carcinoma: radiation therapy alone must be avoided. J Surg Res. https://doi.org/10.1016/j.jss.2019.09.049.

  60. Allal A, Kurtz JM, Pipard G, Marti MC, Miralbell R, Popowski Y, Egeli R (1993) Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 27:59–66. https://doi.org/10.1016/0360-3016(93)90421-Q

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research was conducted without external or internal sources of funding.

Author information

Authors and Affiliations

  1. Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada

    Gaurav Talwar, Oren Levine & Cagla Eskicioglu

  2. Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

    Ryan Daniel

  3. Department of Surgery, Division of General Surgery, McMaster University, Hamilton, Ontario, Canada

    Tyler McKechnie & Cagla Eskicioglu

  4. Department of Oncology, Division of Medical Oncology, McMaster University, Hamilton, Ontario, Canada

    Oren Levine

  5. Department of Surgery, Division of General Surgery, St. Joseph’s Healthcare, 50 Charlton Avenue East, Hamilton, Ontario, Canada

    Cagla Eskicioglu

Authors
  1. Gaurav Talwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan Daniel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tyler McKechnie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oren Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cagla Eskicioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design of the study—all authors.

Acquisition of data—G.T., R.D.

Analysis and interpretation of data—all authors.

Drafting and revision of the manuscript—all authors.

Approval of the final version of the manuscript—all authors.

Corresponding author

Correspondence to Cagla Eskicioglu.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Consent for publication

All authors consent to publication of this work.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(DOCX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Talwar, G., Daniel, R., McKechnie, T. et al. Radiotherapy alone versus chemoradiotherapy for stage I anal squamous cell carcinoma: a systematic review and meta-analysis. Int J Colorectal Dis 36, 1111–1122 (2021). https://doi.org/10.1007/s00384-021-03846-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-021-03846-5

Keywords

Search

Navigation